New Content  edit
Get The App!

Featured Programs

MPN/CML & MDS Weekly - 2019 ASH Special Edition
8 episodes - 1.00 credit hours
Various
Acute Leukemia Weekly - 2019 ASH Special Edition
9 episodes - 1.25 credit hours
Various
Defining the Role of Immune Checkpoint Inhibitor Therapy in Advanced Hepatocellular Carcinoma (HCC)
9 episodes - 1.50 credit hours
Various
Innovative Solutions to Managing Treatment Related Adverse Events
7 episodes - 1.50 credit hours
Various

Featured Videos

Loading the player...




Phase IB/II Study of Nivolumab with Azacytidine in Patients with Relapsed AML
View More Videos

Featured On The Go Programs view all

A Weekly Digital Publication - Acute Leukemia Weekly

Acute Leukemia Weekly: Outcomes 365
18 episodes - non-certified
Various Speakers
Acute Leukemia Weekly: Outcomes 365
79 episodes - non-certified
Various Speakers
AML Special Edition: ASH 2018
10 episodes - non-certified
Various Speakers
Acute Leukemia Weekly: Patient Challenges & Perspectives
9 episodes - non-certified
Various Speakers
Acute Leukemia Weekly Special Edition: ASCO 2018
6 episodes - non-certified
Various Speakers

A Weekly Digital Publication - MPN/CML & MDS Weekly

MPN/CML & MDS Weekly: Outcomes 365
28 episodes - non-certified
Various Speakers
MPN/CML & MDS Weekly: Patient Challenges & Perspectives
1 episodes - non-certified
Various Speakers
MPN/CML & MDS Weekly: Clinical Cases
3 episodes - non-certified
Various Speakers
MPN/CML & MDS Weekly Special Edition: ASCO 2018
2 episodes - non-certified
Various Speakers

A Weekly Digital Publication - GI Weekly

GI Weekly: Outcomes 365
20 episodes - non-certified
Various Speakers
GI Weekly Special Edition: 2019 Gastrointestinal Cancers Symposium
8 episodes - non-certified
Various Speakers
GI Weekly Special Edition: ASCO 2018
5 episodes - non-certified
Various Speakers

Immuno-Oncology

Defining the Role of Immune Checkpoint Inhibitor Therapy in Advanced Hepatocellular Carcinoma (HCC)
9 episodes - 1.50 credit hours
Various
Innovative Solutions to Managing Treatment Related Adverse Events
7 episodes - 1.50 credit hours
Various
Recognizing and Managing Immunotherapy Related Adverse Events
8 episodes - 1.25 credit hours
Various
Cardiopulmonary and Vascular Toxicities Associated with Targeted and Immunotherapies
10 episodes - 1.50 credit hours
Various
Highlights from Oncology Nursing Society (ONS) 2019 – “Growing Together, Transforming Care”
12 episodes - non-certified
Various Speakers
Highlights from Oncology Nursing Society (ONS) 2018 – “One Nurse. One Moment. One Action”
10 episodes - non-certified
Various Speakers
Highlights from Oncology Nursing Society (ONS) 2017 – “Elevate Your Passion”
16 episodes - non-certified
Various Speakers
Optimizing the Treatment Continuum in Metastatic Colorectal Cancer (mCRC)
11 episodes - non-certified
John L. Marshall, MD

Anticoagulation Management & Reversal

2019 ASH Annual Meeting Highlights
11 episodes - non-certified
Various
2019 ISTH Highlights in Thrombosis
29 episodes - non-certified
Various
Thrombosis
1 episodes - non-certified
Manesh R. Patel, MD
Updates in Bleeding Management in Surgery and Trauma: Presented at the AAST Annual Meeting
4 episodes - 1.25 credit hours - Expired
Truman J. Milling Jr., MD, FACEP; Casey O'Connell, MD
Bleeding and DOACs
10 episodes - 1.25 credit hours - Expired
Jerrold H. Levy, MD, FAHA, FCCM
Highlights from THSNA 2018
5 episodes - non-certified
Various Speakers
Highlights from ISTH 2017
11 episodes - non-certified
Various Speakers
Reversal Strategies for Patients Taking Novel Oral Anticoagulants (NOACs)
8 episodes - non-certified
Scott Kaatz, DO, MSc, FACP, SFHM et al.
Highlights from ASH 2016 - Thrombosis & Coagulopathies
8 episodes - non-certified
Various Speakers
Breaking the Barrier to Effective VTE Prevention in Medically Ill Patients
11 episodes - 1.00 credit hour - Expired
C. Michael Gibson, M.S., M.D.

Symptom Management

Recognizing and Managing Immunotherapy Related Adverse Events
8 episodes - 1.25 credit hours
Various
Cardiopulmonary and Vascular Toxicities Associated with Targeted and Immunotherapies
10 episodes - 1.50 credit hours
Various
Highlights from Oncology Nursing Society (ONS) 2019 – “Growing Together, Transforming Care”
12 episodes - non-certified
Various Speakers
Recent Advances in the Treatment of Adult and Pediatric Patients with Hepatic Veno-Occlusive Disease (VOD)
9 episodes - 1.25 credit hours - Expired
Various Speakers
The Multidisciplinary Approach to Screening and Treating Adult and Pediatric Patients with Hepatic Veno-Occlusive Disease (VOD)
8 episodes - 1.25 credit hours
Various Speakers
Highlights from Oncology Nursing Society (ONS) 2018 – “One Nurse. One Moment. One Action”
10 episodes - non-certified
Various Speakers
Preventing Chemotherapy-Induced Nausea and Vomiting (CINV) in the Noncompliant Patient: Alternate Routes of Delivery of Antiemetic Agents
10 episodes - 1.25 credit hours - Expired
Jim Koeller, M.S.
IMPACT Myelofibrosis: Take a Minute to Keep Up
16 episodes - non-certified
Various Speakers
Highlights from Oncology Nursing Society (ONS) 2017 – “Elevate Your Passion”
16 episodes - non-certified
Various Speakers
IMPACT Polycythemia Vera: Take a Minute to Keep Up
14 episodes - non-certified
Various Speakers
Highlights from Oncology Nursing Society (ONS) 2016 – “Big Change Starts Here”
15 episodes - non-certified
Various Speakers
The History of Cannabis and the Endocannabinoid System - Program 1 of 4
5 episodes - non-certified
Donald I. Abrams, M.D., Chief, Hematology-Oncology Division, Zuckerberg San Francisco Hospital
The Use of Cannabinoids in Symptom Management in Patients With Malignant Disease - Program 2 of 4
5 episodes - non-certified
Donald I. Abrams, M.D., Chief, Hematology-Oncology Division, Zuckerberg San Francisco Hospital
Cannabis and Cancer: The Risk of Cancer vs. A Treatment for Cancer - Program 3 of 4
5 episodes - non-certified
Donald I. Abrams, M.D., Chief, Hematology-Oncology Division, Zuckerberg San Francisco General Hospital
Cannabis in Sickle Cell Disease - Program 4 of 4
5 episodes - non-certified
Donald I. Abrams, M.D., Chief, Hematology-Oncology Division, Zuckerberg San Francisco General Hospital
Copyright 2020 by NSCI Group, Inc.